NEW YORK, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Synopsys, Inc. (“Synopsys” or the “Company”) (NASDAQ: SNPS).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

The investigation concerns whether Synopsys and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action]

On September 9, 2025, Synopsys issued a press release reporting its financial results for the third quarter of its 2025 fiscal year. In the press release, Synopsys’s Chief Executive Officer stated that “our IP business underperformed expectations” and said that the Company was “taking a more conservative view of Q4, while guiding another year of profitable growth.” Following these announcements, Baird downgraded Synopsys’s rating to Neutral from Outperform and lowered its price target to $535 from $670.

On this news, Synopsys’s stock price fell $216.59 per share, or 35.84%, to close at $387.78 per share on September 10, 2025.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising. Prior results do not guarantee similar outcomes.   

CONTACT:
Danielle Peyton
Pomerantz LLP
dpeyton@pomlaw.com
646-581-9980 ext. 7980